drugset / Trial / NCT03743194
Pectoralis and Serratus Muscle Blocks
RandomizedParallel-groupDouble-blindTreatment
Summary
The overall research plan is PECS/SAP blocks with liposomal bupivacaine improve the Overall Benefit Analgesia Score averaged over the postoperative days 1, 2, and 3. A 20% reduction on geometric means (i.e., true ratio of geometric means of 0.80) in OBAS will be considered the minimal clinically important benefit.
Timeline
- Start
- 2021-12-14
- Primary completion
- 2022-02-28
- Completion
- 2022-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 266 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.